Calling for Greater Public Accountability in Big Pharma’s Patent Collaborations

March 12th, 2019 by  | No Comments

My beat on is typically, if not all too predictably, the copyright trials and tribulations of scholarly communication. I’d be the first to admit that matters of access to this body of knowledge are relatively straightforward compared to what takes place next door with patent licensing, especially when pharmaceuticals are involved. Still, such patents disputes, which often involve government, university, and industry, can shed light on my interests in legal reforms that restore some part of intellectual property law’s original intent to promote the progress of science and encourage learning for the benefit of all. Read the full article on

Here's your chance to leave a comment!